L2L Microarray Analysis Tool
Results for C07A.profile.u50
| Results summary | View all lists in GO:BiolProc | View all genes in C07A.profile.u50 |
| List Name | Description | Total probes |
Expected matches |
Actual matches |
Fold Enrichment |
Binomial p-value |
|---|---|---|---|---|---|---|
| regulation of embryonic development | Any process that modulates the frequency, rate or extent of embryonic development. | 13 | 0.03 | 2 | 62.24 | 4.68e-04 |
| embryonic development | The process whose specific outcome is the progression of an embryo from its formation until the end of its embryonic life stage. The end of the embryonic stage is organism-specific. For example, for mammals, the process would begin with zygote formation and end with birth. For insects, the process would begin at zygote formation and end with larval hatching. For plant zygotic embryos, this would be from zygote formation to the end of seed dormancy. For plant vegetative embryos, this would be from the initial determination of the cell or group of cells to form an embryo until the point when the embryo becomes independent of the parent plant. | 397 | 0.98 | 5 | 5.09 | 3.33e-03 |
| lymphocyte activation | A change in morphology and behavior of a lymphocyte resulting from exposure to a specific antigen, mitogen, cytokine, chemokine, cellular ligand, or soluble factor. | 269 | 0.66 | 4 | 6.02 | 4.74e-03 |
| leukocyte activation | A change in morphology and behavior of a leukocyte resulting from exposure to a specific antigen, mitogen, cytokine, cellular ligand, or soluble factor. | 305 | 0.75 | 4 | 5.31 | 7.33e-03 |
| regulation of signal transduction | Any process that modulates the frequency, rate or extent of signal transduction. | 682 | 1.69 | 6 | 3.56 | 7.61e-03 |
| immune system process | Any process involved in the development or functioning of the immune system, an organismal system for calibrated responses to potential internal or invasive threats. | 1134 | 2.80 | 8 | 2.85 | 8.10e-03 |
| cell activation | A change in the morphology or behavior of a cell resulting from exposure to an activating factor such as a cellular or soluble ligand. | 330 | 0.82 | 4 | 4.90 | 9.59e-03 |